ISSN: 0929-8673

Journal Home

Journal Guideline

Current Medicinal Chemistry Q1 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Medicinal Chemistry is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 183. It has an SJR impact factor of 0.8 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0.8.

Current Medicinal Chemistry focuses its scope in these topics and keywords: il, factors, emission, electron, examinationbrain, focus, food, futureapproaches, histone, hiv, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Organic Chemistry (Q1) Biochemistry (Q2) Drug Discovery (Q2) Molecular Medicine (Q2) Pharmacology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0.8

SJR Impact factor

183

H Index

400

Total Docs (Last Year)

1146

Total Docs (3 years)

53423

Total Refs

5112

Total Cites (3 years)

1047

Citable Docs (3 years)

4.03

Cites/Doc (2 years)

133.56

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Annual Review of Biophysics Q1
Nature Protocols Q1
Molecular Systems Biology Q1
Chem Q1
Journal of the American Chemical Society Q1

Compare this journals

Aims and Scope

Best articles by citations

Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?

Quantitative Structure - Activity Relationship (QSAR) Studies on Non Steroidal Anti-Inflammatory Drugs (NSAIDs)

Biomedical Applications of Synthetic, Biodegradable Polymers for the Development of Anti-Infective Strategies

p53: An Attractive Therapeutic Target for Cancer

The Use of Naphthoquinones and Furano-naphthoquinones as Antiinvasive Agents

Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition.

Advances in Carbon Based Nanomaterials for Bio-Medical Applications

Sex Steroids and the Endothelium

Highlights in Endocytosis of Nanostructured Systems

Towards Species-specific Antifolates

Structure and Function of Prokaryotic UDP-Glucose Pyrophosphorylase, A Drug Target Candidate

Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)

SHOW MORE ARTICLES

Nanotechnology Based Diagnostic and Therapeutic Strategies for Neuroscience with Special Emphasis on Ischemic Stroke

Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers

Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer

Progresses in the Field of Drug Design to Combat Tropical Protozoan Parasitic Diseases

Engineered Killer Mimotopes: New Synthetic Peptides for Antimicrobial Therapy

Inhibition of Tumor Cell Invasiveness by Chemically Modified Tetracyclines

Functionalized Graphene Oxide as Nanocarrier for Loading and Delivery of Ellagic Acid

Prevention and Treatment of Staphylococcus Biofilms

Combretastatin A-4 Analogues as Antimitotic Antitumor Agents

Antifungal Drug Discovery through the Study of Invertebrate Model Hosts

Computational Modelling of Magnetic Nanoparticle Properties and In Vivo Responses

Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport